ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 41 filers reported holding ELEVATION ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $708,853 | -56.6% | 1,069,805 | -0.5% | 0.00% | – |
Q2 2023 | $1,634,239 | +88.7% | 1,075,157 | +135.9% | 0.00% | – |
Q1 2023 | $865,984 | +173.5% | 455,781 | +36.7% | 0.00% | – |
Q4 2022 | $316,643 | -15.8% | 333,308 | +0.1% | 0.00% | – |
Q3 2022 | $376,000 | -33.0% | 333,024 | -16.9% | 0.00% | – |
Q2 2022 | $561,000 | -40.8% | 400,853 | +6.6% | 0.00% | – |
Q1 2022 | $948,000 | -58.6% | 376,153 | -1.2% | 0.00% | – |
Q4 2021 | $2,292,000 | -55.1% | 380,813 | -41.9% | 0.00% | – |
Q3 2021 | $5,106,000 | +527.3% | 655,409 | +992.3% | 0.00% | – |
Q2 2021 | $814,000 | – | 60,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 2,370,142 | $1,570,456 | 2.08% |
Aisling Capital Management LP | 2,834,910 | $1,878,411 | 0.77% |
venBio Partners LLC | 2,914,255 | $1,930,985 | 0.55% |
TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $2,650,400 | 0.37% |
Velan Capital Investment Management LP | 497,299 | $329,510 | 0.27% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $596,340 | 0.11% |
DAFNA Capital Management LLC | 450,000 | $298,170 | 0.09% |
Ikarian Capital, LLC | 1,171,939 | $776,527 | 0.09% |
CAXTON CORP | 21,813 | $14,453 | 0.06% |
BVF INC/IL | 2,312,200 | $1,532,064 | 0.04% |